Week of November 7, 2023 | Vol. 12, Issue 44

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

The 2023 CPHI Annual Report

CPHI - Oct 2023

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri

Business Wire - Oct 31, 2023

Daiichi Sankyo to absorb manufacturing units in move to leverage ADC strength

Fierce Pharma - Nov 1, 2023

Resolian, the CRO formerly known as Alliance, makes move into China with Denali acquisition

Fierce Biotech - Nov 2, 2023

Cambrex Announces Sale of Drug Product Business Unit

Cambrex - Nov 2, 2023

Radiopharma CDMOs navigate supply chain, raw material challenges as demand goes nuclear

Endpoints News - Nov 2, 2023

Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities

PR Newswire - Nov 2, 2023

TANNER NEWS

Let's Connect!

Meet us at BIO Europe! We look forward to reconnecting with our industry partners. 

🔑 Our Expertise

Access Programs

Clinical Trial Solutions

International Commercialization

Regulatory & Supply Chain Management